This came after Sun Pharma presented the BE study report along with revised clinical trial (CT) protocol no. ICR/23/013 ver.

Oral semaglutide cuts major heart risks in people with type 2 diabetes by 14%, offering a powerful pill-based option. Both ...

The committee noted that semaglutide tablets 3 mg, 7 mg, and 14 mg are approved for marketing in India. The firm has claimed ...

Unlike traditional pharmaceutical manufacturing, which relies on chemical synthesis and fermentation ... 1 receptor agonists like semaglutide but also for other peptide-based therapeutics.

Ophthalmology Times - ophthalmology news, articles, and events in a timely and accurate manner for members of the ophthalmic ...

Others are more direct, recommending peptides for weight loss and describing their experiences using them. These include the usual suspects, like semaglutide and tirzepatide, but also retatrutide ...

As the popularity of peptides continues to rise in 2025, fueled by the success of GLP-1 medications like Semaglutide and Tirzepatide, more individuals are exploring their potential health benefits ...

Semaglutide use associated with increased risk for NAION at the 2-, 3-, and 4-year time point from the index date.